Additionally, mutations affecting the SP-C promoter have been associated with its degradation, resulting in a deficit or absence of SP-C, which likely contributes to the pathogenesis of pulmonary fibrosis [58]. The gene discussed is SFTPC; the disease is pulmonary fibrosis.